selenium has been researched along with Huntington Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, GJS; Patassini, S; Scholefield, M; Xu, J | 1 |
| Bai, R; Chen, C; Cong, W; Li, YF; Wang, L | 1 |
| Abdel Moneim, AE; Abdelfattah, MS; Aref, AM; Attia, GH; Badr, SEA; Kassab, RB; Lotfy, SA | 1 |
| Barrows, L; Bush, AI; Chen, J; Cherny, RA; Chopra, V; Fox, JH; Hersch, S; Lu, Z; Marks, E; Moline, J; Raisbeck, M; Volitakis, I | 1 |
| Solovyev, ND | 1 |
1 review(s) available for selenium and Huntington Disease
| Article | Year |
|---|---|
Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Brain; Glutathione Peroxidase; Humans; Huntington Disease; Mice; Neurons; Neuroprotection; Parkinson Disease; Rats; Schizophrenia; Selenium; Selenoproteins; Synaptic Transmission | 2015 |
4 other study(ies) available for selenium and Huntington Disease
| Article | Year |
|---|---|
Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target.
Topics: Brain; Calcium; Copper; Humans; Huntington Disease; Iron; Manganese; Neurodegenerative Diseases; Potassium; Selenium; Sodium; Zinc | 2023 |
Selenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington's Disease.
Topics: Animals; Animals, Genetically Modified; Caenorhabditis elegans; Cell Death; Disease Models, Animal; Humans; Huntingtin Protein; Huntington Disease; Nanomedicine; Nanoparticles; Neurons; Oxidative Stress; Selenium | 2019 |
Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.
Topics: Animals; bcl-2-Associated X Protein; Brain-Derived Neurotrophic Factor; Caspase 3; Catalase; Corpus Striatum; Down-Regulation; Drug Synergism; Glial Fibrillary Acidic Protein; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Huntington Disease; Interleukin-1beta; Male; Malondialdehyde; Mice; Neuroprotective Agents; Nitric Oxide; Nitro Compounds; Oxidative Stress; Peroxidase; Propionates; Proto-Oncogene Proteins c-bcl-2; Rutin; Selenium; Superoxide Dismutase; Synaptic Transmission; Tumor Necrosis Factor-alpha; Up-Regulation | 2020 |
Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
Topics: Adult; Animals; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Motor Activity; Nerve Tissue Proteins; Neuroprotective Agents; Selenious Acid; Selenium; Survival Analysis; Time Factors; Trinucleotide Repeat Expansion | 2014 |